Article Versions Notes

Vicenti I, Basso M, Pirola N, Bragato B, Rossi MC, Giobbia M, Pascoli S, Vinci A, Caputo S, Varasi I, et al. SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy. Vaccines. 2023; 11(4):871. https://doi.org/10.3390/vaccines11040871

Vicenti, Ilaria, Monica Basso, Nicole Pirola, Beatrice Bragato, Maria Cristina Rossi, Mario Giobbia, Susanna Pascoli, Antonio Vinci, Sara Caputo, Ilenia Varasi, and et al. 2023. "SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy" Vaccines 11, no. 4: 871. https://doi.org/10.3390/vaccines11040871

Vicenti, I., Basso, M., Pirola, N., Bragato, B., Rossi, M. C., Giobbia, M., Pascoli, S., Vinci, A., Caputo, S., Varasi, I., Biba, C., Fiaschi, L., Zazzi, M., & Parisi, S. G. (2023). SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy. Vaccines, 11(4), 871. https://doi.org/10.3390/vaccines11040871